BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Ehms B, Kaemmerer D, Sänger J, Schulz S, Lupp A. Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61. Sci Rep 2022;12:14722. [PMID: 36042228 DOI: 10.1038/s41598-022-19014-w] [Reference Citation Analysis]
2 Pedraza-Arevalo S, Alors-Pérez E, Blázquez-Encinas R, Herrera-Martínez AD, Jiménez-Vacas JM, Fuentes-Fayos AC, Reyes Ó, Ventura S, Sánchez-Sánchez R, Ortega-Salas R, Serrano-Blanch R, Gálvez-Moreno MA, Gahete MD, Ibáñez-Costa A, Luque RM, Castaño JP. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. Transl Res 2022:S1931-5244(22)00170-0. [PMID: 35882361 DOI: 10.1016/j.trsl.2022.07.005] [Reference Citation Analysis]
3 Zhao R, Shi H, Yin J, Sun Z, Xu Y. Promoter Specific Methylation of SSTR4 is Associated With Alcohol Dependence in Han Chinese Males. Front Genet 2022;13:915513. [PMID: 35754825 DOI: 10.3389/fgene.2022.915513] [Reference Citation Analysis]
4 Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W, Wang M, Zhou Q, Chen S, Xu W, Du J, Chu X, Yi C, Dai A, Hu L, Shen MY, Sun Y, Zhang Q, Ma Y, Zhong W, Yang D, Wang MW, Wu B, Zhao Q. Structural insights into ligand recognition and selectivity of somatostatin receptors. Cell Res 2022. [PMID: 35739238 DOI: 10.1038/s41422-022-00679-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Martinovich VP, Baradzina KU. Peptide Hormones in Medicine: A 100-Year History. Russ J Bioorg Chem 2022;48:221-32. [DOI: 10.1134/s1068162022020157] [Reference Citation Analysis]
6 Manneh Kopp R, Espinosa-Olarte P, Alonso-Gordoa T. Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging. Cancers (Basel) 2022;14:2514. [PMID: 35626118 DOI: 10.3390/cancers14102514] [Reference Citation Analysis]
7 Chen LN, Wang WW, Dong YJ, Shen DD, Guo J, Yu X, Qin J, Ji SY, Zhang H, Shen Q, He Q, Yang B, Zhang Y, Li Q, Mao C. Structures of the endogenous peptide- and selective non-peptide agonist-bound SSTR2 signaling complexes. Cell Res 2022. [PMID: 35578016 DOI: 10.1038/s41422-022-00669-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yan J, Chen M, Chen Y, Chuang C, Hsu P, Wei K, Chang C. Surgical Outcome and Evaluation of Strategies in the Management of Growth Hormone-Secreting Pituitary Adenomas After Initial Transsphenoidal Pituitary Adenectomy Failure. Front Endocrinol 2022;13:756855. [DOI: 10.3389/fendo.2022.756855] [Reference Citation Analysis]
9 Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY. Clinical Biology of the Pituitary Adenoma. Endocr Rev 2022:bnac010. [PMID: 35395078 DOI: 10.1210/endrev/bnac010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Flauaus C, Engel P, Zhou F, Petersen J, Ruth P, Lukowski R, Schmidtko A, Lu R. Slick Potassium Channels Control Pain and Itch in Distinct Populations of Sensory and Spinal Neurons in Mice. Anesthesiology 2022. [PMID: 35303056 DOI: 10.1097/ALN.0000000000004163] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fani M, Mansi R, Nicolas GP, Wild D. Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals. Cancers (Basel) 2022;14:1172. [PMID: 35267479 DOI: 10.3390/cancers14051172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang Y, Yañez-Guerra LA, Tinoco AB, Escudero Castelán N, Egertová M, Elphick MR. Somatostatin-type and allatostatin-C-type neuropeptides are paralogous and have opposing myoregulatory roles in an echinoderm. Proc Natl Acad Sci U S A 2022;119:e2113589119. [PMID: 35145030 DOI: 10.1073/pnas.2113589119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ershadinia N, Tritos NA. Diagnosis and Treatment of Acromegaly: An Update. Mayo Clinic Proceedings 2022;97:333-46. [DOI: 10.1016/j.mayocp.2021.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Rogoza O, Megnis K, Kudrjavceva M, Gerina-Berzina A, Rovite V. Role of Somatostatin Signalling in Neuroendocrine Tumours. Int J Mol Sci 2022;23:1447. [PMID: 35163374 DOI: 10.3390/ijms23031447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Del Olmo-García MI, Prado-Wohlwend S, Bello P, Segura A, Merino-Torres JF. Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions. Cancers (Basel) 2022;14:584. [PMID: 35158852 DOI: 10.3390/cancers14030584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fuentes-Fayos AC, G-García ME, Pérez-Gómez JM, Peel A, Blanco-Acevedo C, Solivera J, Ibáñez-Costa A, Gahete MD, Castaño JP, Luque RM. Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. Int J Mol Sci 2022;23:1143. [PMID: 35163067 DOI: 10.3390/ijms23031143] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Alexandraki KI, Zatelli MC, Grossman AB. "The past is a different country, they do things differently there": using the SEER data-base to assess prognosis in neuroendocrine tumours. Endocrine 2022. [PMID: 35037238 DOI: 10.1007/s12020-021-02959-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mansi R, Plas P, Vauquelin G, Fani M. Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE. Pharmaceuticals (Basel) 2021;14:1265. [PMID: 34959665 DOI: 10.3390/ph14121265] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Tulipano G. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area. Int J Mol Sci 2021;22:13068. [PMID: 34884872 DOI: 10.3390/ijms222313068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Del Olmo-Garcia MI, Prado-Wohlwend S, Andres A, Soriano JM, Bello P, Merino-Torres JF. Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms. Biomedicines 2021;9:1810. [PMID: 34944626 DOI: 10.3390/biomedicines9121810] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Lupp A, Ehms B, Stumm R, Göckeritz J, Mawrin C, Schulz S. Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61. Int J Mol Sci 2021;22:12981. [PMID: 34884783 DOI: 10.3390/ijms222312981] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Watamura N, Kakiya N, Nilsson P, Tsubuki S, Kamano N, Takahashi M, Hashimoto S, Sasaguri H, Saito T, Saido TC. Somatostatin-evoked Aβ catabolism in the brain: Mechanistic involvement of α-endosulfine-KATP channel pathway. Mol Psychiatry 2021. [PMID: 34737456 DOI: 10.1038/s41380-021-01368-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Dasgupta P, Gűnther T, Schulz S. Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist. Life (Basel) 2021;11:1075. [PMID: 34685446 DOI: 10.3390/life11101075] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Pedraza-Arevalo S, Ibáñez-Costa A, Blázquez-Encinas R, Branco MR, Vázquez-Borrego MC, Herrera-Martínez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sánchez Á, Gálvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castaño JP. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors. Mol Oncol 2022;16:764-79. [PMID: 34601790 DOI: 10.1002/1878-0261.13107] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Raven F, Aton SJ. The Engram's Dark Horse: How Interneurons Regulate State-Dependent Memory Processing and Plasticity. Front Neural Circuits 2021;15:750541. [PMID: 34588960 DOI: 10.3389/fncir.2021.750541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Racine AS, Michon FX, Laplante I, Lacaille JC. Somatostatin contributes to long-term potentiation at excitatory synapses onto hippocampal somatostatinergic interneurons. Mol Brain 2021;14:130. [PMID: 34429141 DOI: 10.1186/s13041-021-00830-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Neumann WL, Sandoval KE, Mobayen S, Minaeian M, Kukielski SG, Srabony KN, Frare R, Slater O, Farr SA, Niehoff ML, Hospital A, Kontoyianni M, Crider AM, Witt KA. Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment. RSC Med Chem 2021;12:1352-65. [PMID: 34458738 DOI: 10.1039/d1md00044f] [Reference Citation Analysis]
29 Zhang L, Pan K, Zuo Z, Ye F, Cao D, Peng Y, Tang T, Li X, Zhou S, Duan L. LINC01133 hampers the development of gastric cancer through increasing somatostatin via binding to microRNA-576-5p. Epigenomics 2021;13:1205-19. [PMID: 34318683 DOI: 10.2217/epi-2020-0377] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Belhabib I, Zaghdoudi S, Lac C, Bousquet C, Jean C. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy? Cancers (Basel) 2021;13:3466. [PMID: 34298680 DOI: 10.3390/cancers13143466] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
31 Gulde S, Wiedemann T, Schillmaier M, Valença I, Lupp A, Steiger K, Yen HY, Bäuerle S, Notni J, Luque R, Schmid H, Schulz S, Ankerst DP, Schilling F, Pellegata NS. Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors. Cancers (Basel) 2021;13:3097. [PMID: 34205778 DOI: 10.3390/cancers13123097] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Honoré E, Khlaifia A, Bosson A, Lacaille JC. Hippocampal Somatostatin Interneurons, Long-Term Synaptic Plasticity and Memory. Front Neural Circuits 2021;15:687558. [PMID: 34149368 DOI: 10.3389/fncir.2021.687558] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
33 Pittaluga A, Roggeri A, Vallarino G, Olivero G. Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System. Int J Mol Sci 2021;22:5864. [PMID: 34070785 DOI: 10.3390/ijms22115864] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
34 Hu Y, Ye Z, Wang F, Qin Y, Xu X, Yu X, Ji S. Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy. Front Endocrinol (Lausanne) 2021;12:679000. [PMID: 34093445 DOI: 10.3389/fendo.2021.679000] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
35 Bönisch H, Fink KB, Malinowska B, Molderings GJ, Schlicker E. Serotonin and beyond-a tribute to Manfred Göthert (1939-2019). Naunyn Schmiedebergs Arch Pharmacol 2021;394:1829-67. [PMID: 33991216 DOI: 10.1007/s00210-021-02083-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Stokman MF, Saunier S, Benmerah A. Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis. Front Cell Dev Biol 2021;9:653138. [PMID: 34055783 DOI: 10.3389/fcell.2021.653138] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Amarù J, Barbieri F, Arvigo M, Solari A, Bajetto A, Nista F, Campana C, Gaggero G, Prior A, Criminelli Rossi D, Zona G, Ferone D, Florio T, Gatto F. Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects. Cancers (Basel) 2021;13:1816. [PMID: 33920241 DOI: 10.3390/cancers13081816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Duong Phu M, Bross S, Burkhalter MD, Philipp M. Limitations and opportunities in the pharmacotherapy of ciliopathies. Pharmacol Ther 2021;225:107841. [PMID: 33771583 DOI: 10.1016/j.pharmthera.2021.107841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shamsi BH, Chatoo M, Xu XK, Xu X, Chen XQ. Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System. Front Endocrinol (Lausanne) 2021;12:652363. [PMID: 33796080 DOI: 10.3389/fendo.2021.652363] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
40 Picech F, Sosa LD, Perez PA, Cecenarro L, Oms SR, Coca HA, De Battista JC, Gutiérrez S, Mukdsi JH, Torres AI, Petiti JP. TGF-β1/Smad2/3 signaling pathway modulates octreotide antisecretory and antiproliferative effects in pituitary somatotroph tumor cells. J Cell Physiol 2021;236:6974-87. [PMID: 33682941 DOI: 10.1002/jcp.30360] [Reference Citation Analysis]
41 De Ravin E, Phan HAT, Harmsen S, Cho SS, Teng CW, Petersson EJ, White C, Galban EM, Hess R, Lee JYK. Somatostatin Receptor as a Molecular Imaging Target in Human and Canine Cushing Disease. World Neurosurg 2021;149:94-102. [PMID: 33601082 DOI: 10.1016/j.wneu.2021.02.034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ionovici N, Carsote M, Terzea DC, Predescu AM, Rauten AM, Popescu M. Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review. Rom J Morphol Embryol 2020;61:353-9. [PMID: 33544787 DOI: 10.47162/RJME.61.2.05] [Reference Citation Analysis]
43 Cantone MC, Dicitore A, Vitale G. Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms. J Clin Med 2021;10:501. [PMID: 33535394 DOI: 10.3390/jcm10030501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Tulipano G, Giustina A. Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells. Pituitary 2020;23:223-31. [PMID: 31997055 DOI: 10.1007/s11102-020-01028-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Zhang Y, Liu T, Wang J, Zou B, Li L, Yao L, Chen K, Ning L, Wu B, Zhao X, Wang D. Cellinker: a platform of ligand-receptor interactions for intercellular communication analysis. Bioinformatics 2021:btab036. [PMID: 33471060 DOI: 10.1093/bioinformatics/btab036] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
46 Liu TT, Wei S, Jin Y, Qiu CY, Hu WP. Inhibition of ASIC-Mediated Currents by Activation of Somatostatin 2 Receptors in Rat Dorsal Root Ganglion Neurons. Mol Neurobiol 2021;58:2107-17. [PMID: 33411247 DOI: 10.1007/s12035-020-02257-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Pöstyéni E, Kovács-Valasek A, Dénes V, Mester A, Sétáló G Jr, Gábriel R. PACAP for Retinal Health: Model for Cellular Aging and Rescue. Int J Mol Sci 2021;22:E444. [PMID: 33466261 DOI: 10.3390/ijms22010444] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Xiao X, Bi M, Jiao Q, Chen X, Du X, Jiang H. A new understanding of GHSR1a--independent of ghrelin activation. Ageing Res Rev 2020;64:101187. [PMID: 33007437 DOI: 10.1016/j.arr.2020.101187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
49 Tulipano G. Role of Bioactive Peptide Sequences in the Potential Impact of Dairy Protein Intake on Metabolic Health. Int J Mol Sci 2020;21:E8881. [PMID: 33238654 DOI: 10.3390/ijms21228881] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
50 Siddiqui M, Vora A, Ali S, Abramowitz J, Mirfakhraee S. Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia. J Endocr Soc 2021;5:bvaa171. [PMID: 33294765 DOI: 10.1210/jendso/bvaa171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
51 Klomp MJ, Dalm SU, de Jong M, Feelders RA, Hofland J, Hofland LJ. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer. Rev Endocr Metab Disord 2021;22:495-510. [PMID: 33085037 DOI: 10.1007/s11154-020-09607-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
52 Costanzi E, Simioni C, Conti I, Laface I, Varano G, Brenna C, Neri LM. Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives. J Cell Physiol 2021;236:2505-18. [PMID: 32989768 DOI: 10.1002/jcp.30062] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Csaba Z, Vitalis T, Charriaut-Marlangue C, Margaill I, Coqueran B, Leger PL, Parente I, Jacquens A, Titomanlio L, Constans C, Demene C, Santin MD, Lehericy S, Perrière N, Glacial F, Auvin S, Tanter M, Ghersi-Egea JF, Adle-Biassette H, Aubry JF, Gressens P, Dournaud P. A simple novel approach for detecting blood-brain barrier permeability using GPCR internalization. Neuropathol Appl Neurobiol 2021;47:297-315. [PMID: 32898926 DOI: 10.1111/nan.12665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Flores-Martinez Á, Venegas-Moreno E, Dios E, Remón-Ruiz P, Gros-Herguido N, Vázquez-Borrego MC, Madrazo-Atutxa A, Japón MA, Kaen A, Cárdenas-Valdepeñas E, Roldán F, Castaño JP, Luque RM, Cano DA, Soto-Moreno A. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features. J Clin Med 2020;9:E3052. [PMID: 32971845 DOI: 10.3390/jcm9093052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Campana C, Corica G, Nista F, Cocchiara F, Graziani G, Khorrami K, Franco M, Boschetti M, Ferone D, Gatto F. Emerging drugs for the treatment of acromegaly. Expert Opin Emerg Drugs 2020;25:409-17. [PMID: 32938258 DOI: 10.1080/14728214.2020.1819983] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Zhang Y, Yañez Guerra LA, Egertová M, Zampronio CG, Jones AM, Elphick MR. Molecular and functional characterization of somatostatin-type signalling in a deuterostome invertebrate. Open Biol 2020;10:200172. [PMID: 32898470 DOI: 10.1098/rsob.200172] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
57 Wu W, Zhou Y, Wang Y, Liu L, Lou J, Deng Y, Zhao P, Shao A. Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma. Front Oncol 2020;10:1633. [PMID: 33014821 DOI: 10.3389/fonc.2020.01633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
58 Eychenne R, Bouvry C, Bourgeois M, Loyer P, Benoist E, Lepareur N. Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy. Molecules 2020;25:E4012. [PMID: 32887456 DOI: 10.3390/molecules25174012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 17.0] [Reference Citation Analysis]
59 Mahfud M, Ernawati E, Mahmud NRA, Budipitojo T, Wijayanto H. An immunohistochemical study of endocrine cells in the digestive tract of Varanus salvator (Reptile: Varanidae). Vet World 2020;13:1737-42. [PMID: 33132583 DOI: 10.14202/vetworld.2020.1737-1742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Zou R, Zheng M, Tan M, Xu H, Luan N, Zhu L. Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation. Cancer Manag Res 2020;12:5057-75. [PMID: 32617019 DOI: 10.2147/CMAR.S255753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
61 Marques P, Grossman AB, Korbonits M. The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol 2020;58:100852. [PMID: 32553750 DOI: 10.1016/j.yfrne.2020.100852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
62 Varga AG, Maletz SN, Bateman JT, Reid BT, Levitt ES. Neurochemistry of the Kölliker-Fuse nucleus from a respiratory perspective. J Neurochem 2021;156:16-37. [PMID: 32396650 DOI: 10.1111/jnc.15041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
63 Lau J, Rousseau E, Kwon D, Lin KS, Bénard F, Chen X. Insight into the Development of PET Radiopharmaceuticals for Oncology. Cancers (Basel) 2020;12:E1312. [PMID: 32455729 DOI: 10.3390/cancers12051312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
64 Leff ER, Arttamangkul S, Williams JT. Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs. Mol Pharmacol 2020;98:497-507. [PMID: 32362586 DOI: 10.1124/mol.119.119362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
65 Tonon M, Vaudry H, Chuquet J, Guillebaud F, Fan J, Masmoudi-kouki O, Vaudry D, Lanfray D, Morin F, Prevot V, Papadopoulos V, Troadec J, Leprince J. Endozepines and their receptors: Structure, functions and pathophysiological significance. Pharmacology & Therapeutics 2020;208:107386. [DOI: 10.1016/j.pharmthera.2019.06.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
66 Gimeno RE, Briere DA, Seeley RJ. Leveraging the Gut to Treat Metabolic Disease. Cell Metab 2020;31:679-98. [PMID: 32187525 DOI: 10.1016/j.cmet.2020.02.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
67 Sobrido-Cameán D, Tostivint H, Mazan S, Rodicio MC, Rodríguez-Moldes I, Candal E, Anadón R, Barreiro-Iglesias A. Differential expression of five prosomatostatin genes in the central nervous system of the catshark Scyliorhinus canicula. J Comp Neurol 2020;528:2333-60. [PMID: 32141087 DOI: 10.1002/cne.24898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
68 Alexandraki KI, Daskalakis K, Tsoli M, Grossman AB, Kaltsas GA. Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Trends in Endocrinology & Metabolism 2020;31:239-55. [DOI: 10.1016/j.tem.2019.11.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Somatostatin Analogs in Clinical Practice: a Review. Int J Mol Sci 2020;21:E1682. [PMID: 32121432 DOI: 10.3390/ijms21051682] [Cited by in Crossref: 26] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
70 Tulipano G. How treatments with endocrine and metabolic drugs influence pituitary cell function. Endocr Connect 2020;9:R14-27. [PMID: 31905162 DOI: 10.1530/EC-19-0482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
71 Lukomska A, Dobrzanski G, Liguz-Lecznar M, Kossut M. Somatostatin receptors (SSTR1-5) on inhibitory interneurons in the barrel cortex. Brain Struct Funct 2020;225:387-401. [PMID: 31873798 DOI: 10.1007/s00429-019-02011-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
72 Theodoropoulou M, Reincke M. Tumor-Directed Therapeutic Targets in Cushing Disease. J Clin Endocrinol Metab 2019;104:925-33. [PMID: 30535260 DOI: 10.1210/jc.2018-02080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
73 Alexandraki KI, Daskalakis K, Tsoli M, Grossman AB, Kaltsas GA. Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Trends Endocrinol Metab 2020;31:239-55. [PMID: 31839442 DOI: 10.1016/j.tem.2019.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Kántás B, Börzsei R, Szőke É, Bánhegyi P, Horváth Á, Hunyady Á, Borbély É, Hetényi C, Pintér E, Helyes Z. Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain. Int J Mol Sci 2019;20:E6245. [PMID: 31835716 DOI: 10.3390/ijms20246245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
75 Iglesias P, Magallón R, Mitjavila M, Rodríguez Berrocal V, Pian H, Díez JJ. Multimodal therapy in aggressive pituitary tumors. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:469-85. [PMID: 31740190 DOI: 10.1016/j.endinu.2019.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Sandoval K, Umbaugh D, House A, Crider A, Witt K. Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice. Neurochem Res 2019;44:2670-80. [PMID: 31630317 DOI: 10.1007/s11064-019-02890-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
77 Lv Z, Jin S, Ding H, Zou Q. A Random Forest Sub-Golgi Protein Classifier Optimized via Dipeptide and Amino Acid Composition Features. Front Bioeng Biotechnol 2019;7:215. [PMID: 31552241 DOI: 10.3389/fbioe.2019.00215] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
78 Del Rio-Moreno M, Alors-Perez E, Borges de Souza P, Prados-Gonzalez ME, CastaÑo JP, Luque RM, Gahete MD. Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types. Transl Res 2019;211:147-60. [PMID: 30904441 DOI: 10.1016/j.trsl.2019.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
79 Gatto F, Barbieri F, Arvigo M, Thellung S, Amarù J, Albertelli M, Ferone D, Florio T. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. Int J Mol Sci 2019;20:E3940. [PMID: 31412614 DOI: 10.3390/ijms20163940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
80 Tostivint H, Gaillard A, Mazan S, Pézeron G. Revisiting the evolution of the somatostatin family: Already five genes in the gnathostome ancestor. General and Comparative Endocrinology 2019;279:139-47. [DOI: 10.1016/j.ygcen.2019.02.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
81 Linciano S, Pluda S, Bacchin A, Angelini A. Molecular evolution of peptides by yeast surface display technology. Medchemcomm 2019;10:1569-80. [PMID: 31803399 DOI: 10.1039/c9md00252a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
82 Vázquez-Borrego MC, L-López F, Gálvez-Moreno MA, Fuentes-Fayos AC, Venegas-Moreno E, Herrera-Martínez AD, Blanco-Acevedo C, Solivera J, Landsman T, Gahete MD, Soto-Moreno A, Culler MD, Castaño JP, Luque RM. A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells. Neuroendocrinology 2020;110:70-82. [PMID: 31272096 DOI: 10.1159/000500812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
83 Park TSW, Khan N, Kuo A, Nicholson JR, Corradini L, Smith MT. J-2156, a somatostatin receptor type 4 agonist, alleviates mechanical hyperalgesia in a rat model of chronic low back pain. Biomed Pharmacother 2019;117:109056. [PMID: 31181441 DOI: 10.1016/j.biopha.2019.109056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
84 Cammalleri M, Bagnoli P, Bigiani A. Molecular and Cellular Mechanisms Underlying Somatostatin-Based Signaling in Two Model Neural Networks, the Retina and the Hippocampus. Int J Mol Sci 2019;20:E2506. [PMID: 31117258 DOI: 10.3390/ijms20102506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
85 Bowman BR, Bokiniec P, McMullan S, Goodchild AK, Burke PGR. Somatostatin 2 Receptors in the Spinal Cord Tonically Restrain Thermogenic, Cardiac and Other Sympathetic Outflows. Front Neurosci 2019;13:121. [PMID: 30842723 DOI: 10.3389/fnins.2019.00121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
86 Gatto F, Arvigo M, Amarù J, Campana C, Cocchiara F, Graziani G, Bruzzone E, Giusti M, Boschetti M, Ferone D. Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells. Pituitary 2019;22:89-99. [PMID: 30483918 DOI: 10.1007/s11102-018-0926-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
87 Soukup J, Kasparova P, Kohout A, Rychly B, Skarkova V, Syrucek M, Gabalec F. Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary. Pituitary 2019;22:70-8. [DOI: 10.1007/s11102-018-00935-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
88 Zou Y, Tan H, Zhao Y, Zhou Y, Cao L. Expression and selective activation of somatostatin receptor subtypes induces cell cycle arrest in cancer cells. Oncol Lett 2019;17:1723-31. [PMID: 30675231 DOI: 10.3892/ol.2018.9773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]